2016 Fiscal Year Final Research Report
Involvement and activation mechanism of novel PAMPs in lung mycoses
| Project/Area Number |
15K19098
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Bacteriology (including mycology)
|
|---|
| Research Institution | Tokyo University of Pharmacy and Life Science |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2015-04-01 – 2017-03-31
|
| Keywords | 病原真菌 / アスペルギルス / PAMPs / 感染防御 |
|---|
| Outline of Final Research Achievements |
Aspergillus is a medically important fungal genus that can cause a life-threatening infection called aspergillosis in immunocompromised patients. The α-1,3-glucan is the one of main components of Aspergillus cell wall. However, the immunological activity of α-1,3-glucan is not fully characterized. In this study, we prepared soluble and insoluble Aspergillus cell wall α-1,3-glucanand examined the immunological activity.
The Aspergillus cell wall insoluble and soluble α-1,3-glucan (AspAG and ASAG) was prepared from acetone-dried mycerium. AspAG induced inflammatory cytokine production in a dose-dependent manner, but ASAG did not in vitro. AspAG induced inflammatory response such as increased vascular permeability and priming effect to PAMPs in vivo. Anti-ASAG antibody was detected in the serum of each human volunteer. From these findings, Aspergillus cell wall α-1,3-glucan is important molecule in the pathology of Aspergillus related infectious diseases.
|
| Free Research Field |
感染免疫学
|
